128 related articles for article (PubMed ID: 1635750)
1. Prevention of neonatal group B streptococcal infections: advances in maternal vaccine development.
Coleman RT; Sherer DM; Maniscalco WM
Obstet Gynecol; 1992 Aug; 80(2):301-9. PubMed ID: 1635750
[TBL] [Abstract][Full Text] [Related]
2. Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus.
Baker CJ; Rench MA; Edwards MS; Carpenter RJ; Hays BM; Kasper DL
N Engl J Med; 1988 Nov; 319(18):1180-5. PubMed ID: 3050524
[TBL] [Abstract][Full Text] [Related]
3. Neonatal early-onset group B streptococcal disease in the era of intrapartum chemoprophylaxis: residual problems.
Pinto NM; Soskolne EI; Pearlman MD; Faix RG
J Perinatol; 2003 Jun; 23(4):265-71. PubMed ID: 12774131
[TBL] [Abstract][Full Text] [Related]
4. [Obstetric prevention of neonatal infections caused by group B beta-hemolytic Streptococcus].
Diani F; Turinetto A; Tanganelli E
Pediatr Med Chir; 1995; 17(4):307-9. PubMed ID: 7491324
[TBL] [Abstract][Full Text] [Related]
5. An analysis of the cost-effectiveness of selected protocols for the prevention of neonatal group B streptococcal infection.
Yancey MK; Duff P
Obstet Gynecol; 1994 Mar; 83(3):367-71. PubMed ID: 8127527
[TBL] [Abstract][Full Text] [Related]
6. Performance of a group B streptococcal prophylaxis protocol combining high-risk treatment and low-risk screening.
Reisner DP; Haas MJ; Zingheim RW; Williams MA; Luthy DA
Am J Obstet Gynecol; 2000 Jun; 182(6):1335-43. PubMed ID: 10871447
[TBL] [Abstract][Full Text] [Related]
7. Maternal group B streptococcal immunization: capsular polysaccharide (CPS)-based vaccines and their implications on prevention.
Palmeiro JK; De Carvalho NS; Botelho AC; Fracalanzza SE; Madeira HM; Dalla-Costa LM
Vaccine; 2011 May; 29(21):3729-30. PubMed ID: 21414381
[TBL] [Abstract][Full Text] [Related]
8. Vaccines for other neonatal infections: are group B streptococcal infections vaccine-preventable?
Gilbert GL
Expert Rev Vaccines; 2004 Aug; 3(4):371-4. PubMed ID: 15270637
[TBL] [Abstract][Full Text] [Related]
9. Group B streptococcal neonatal infection: clinical review of plans for prevention and preliminary report of quantitative antepartum cultures.
Bobitt JR; Brown GL; Tull AH
Obstet Gynecol; 1980 May; 55(5 Suppl):171S-177S. PubMed ID: 6990332
[TBL] [Abstract][Full Text] [Related]
10. Prevention of neonatal group B streptococcal infection.
Keenan C
Am Fam Physician; 1998 Jun; 57(11):2713-20, 2725. PubMed ID: 9636335
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease.
Lin FY; Brenner RA; Johnson YR; Azimi PH; Philips JB; Regan JA; Clark P; Weisman LE; Rhoads GG; Kong F; Clemens JD
Am J Obstet Gynecol; 2001 May; 184(6):1204-10. PubMed ID: 11349189
[TBL] [Abstract][Full Text] [Related]
12. Early-onset group B streptococcal disease in the era of maternal screening.
Puopolo KM; Madoff LC; Eichenwald EC
Pediatrics; 2005 May; 115(5):1240-6. PubMed ID: 15867030
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of early-onset neonatal group B streptococcal infection: implications for screening.
Konrad G; Katz A
Can Fam Physician; 2007 Jun; 53(6):1055, 2001:e.1-6, 1054. PubMed ID: 17872785
[TBL] [Abstract][Full Text] [Related]
14. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection.
Baker CJ; Kasper DL
N Engl J Med; 1976 Apr; 294(14):753-6. PubMed ID: 768760
[TBL] [Abstract][Full Text] [Related]
15. Conjugate vaccines against group B Streptococcus types IV and VII.
Paoletti LC; Kasper DL
J Infect Dis; 2002 Jul; 186(1):123-6. PubMed ID: 12089673
[TBL] [Abstract][Full Text] [Related]
16. A trial of preventing early- and late-onset Group B streptococcal sepsis with combined intrapartum chemoprophylaxis and universal neonatal screening.
Bertini G; Dani C; Cianciulli D; Rubaltelli FF; Nicoletti P
J Perinat Med; 2006; 34(5):420-4. PubMed ID: 16965231
[TBL] [Abstract][Full Text] [Related]
17. Group B streptococcal immunisation of pregnant women for the prevention of early and late onset Group B streptococcal infection of the neonate as well as adult disease.
Kenchington AL; Lamont RF
Expert Rev Vaccines; 2017 Jan; 16(1):15-25. PubMed ID: 27385362
[TBL] [Abstract][Full Text] [Related]
18. Neonatal group B streptococcal infection prevention.
Erramouspe J; Lourwood DL
Ann Pharmacother; 1994 Apr; 28(4):474-5. PubMed ID: 8038472
[No Abstract] [Full Text] [Related]
19. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib.
Baker CJ; Paoletti LC; Wessels MR; Guttormsen HK; Rench MA; Hickman ME; Kasper DL
J Infect Dis; 1999 Jan; 179(1):142-50. PubMed ID: 9841833
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial prophylaxis of neonatal group B streptococcal sepsis.
Boyer KM; Gotoff SP
Clin Perinatol; 1988 Dec; 15(4):831-50. PubMed ID: 3061701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
